Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cytostatic polychemotherapy in the aged].

W Wilmanns, T Binsack, H Sauer

    Deutsche Medizinische Wochenschrift (1946)
    |December 20, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?

    Acta psychiatrica Scandinavica·2012
    Same author

    Heart rate variability in the irritable bowel syndrome: a review of the literature.

    Neurogastroenterology and motility·2012
    Same author

    A vegan or vegetarian diet substantially alters the human colonic faecal microbiota.

    European journal of clinical nutrition·2011
    Same author

    Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts.

    Restorative neurology and neuroscience·2011
    Same author

    Temporal and right frontal lobe alterations in panic disorder: a quantitative volumetric and voxel-based morphometric MRI study.

    Psychological medicine·2010
    Same author

    Intensive practice of a cognitive task is associated with enhanced functional integration in schizophrenia.

    Psychological medicine·2009

    Older patients receiving combination chemotherapy showed more treatment deviations, likely due to pre-existing conditions, not age itself. Severe pre-existing diseases significantly impact chemotherapy toxicity.

    Area of Science:

    • Oncology
    • Clinical Pharmacology

    Background:

    • Combination chemotherapy is a standard treatment for malignant lymphoma and breast cancer.
    • Patient age and pre-existing conditions can influence treatment tolerance and outcomes.

    Purpose of the Study:

    • To retrospectively analyze adherence to chemotherapy regimens in elderly versus younger patients.
    • To determine the impact of age and pre-existing diseases on chemotherapy toxicity and dose modifications.

    Main Methods:

    • Retrospective analysis of 1446 chemotherapy courses from 291 patients with malignant lymphoma and breast cancer.
    • Comparison of treatment deviations (dose adherence, dose reduction, interval changes) between age groups and across different chemotherapy regimens (COP, COPP, CHOP).

    Main Results:

    Related Experiment Videos

    • Patients over 60 experienced significantly more deviations from standard regimens with COP and COPP, attributed to non-oncological comorbidities.
    • No significant difference in deviations was observed in the CHOP regimen group, where patients with severe pre-existing diseases were excluded.
    • Pre-existing diseases were identified as a substantial factor in cytostatic toxicity.

    Conclusions:

    • Age alone is not a primary risk factor for combination chemotherapy.
    • Pre-existing non-oncological diseases significantly influence the toxicity and management of chemotherapy, necessitating careful patient selection and monitoring.